AU562517B2 - Biostimulating agent containing creatine - Google Patents

Biostimulating agent containing creatine

Info

Publication number
AU562517B2
AU562517B2 AU15432/83A AU1543283A AU562517B2 AU 562517 B2 AU562517 B2 AU 562517B2 AU 15432/83 A AU15432/83 A AU 15432/83A AU 1543283 A AU1543283 A AU 1543283A AU 562517 B2 AU562517 B2 AU 562517B2
Authority
AU
Australia
Prior art keywords
hydrolyzate
weight
agent containing
creatine
containing creatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15432/83A
Other languages
English (en)
Other versions
AU1543283A (en
Inventor
Pencho Varbanov Burov
Mihail Stefanov Kirov
Ivan Hristov Kovachev
Ivan Hristov Radoslovov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of AU1543283A publication Critical patent/AU1543283A/en
Application granted granted Critical
Publication of AU562517B2 publication Critical patent/AU562517B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU15432/83A 1982-06-09 1983-06-07 Biostimulating agent containing creatine Ceased AU562517B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823221827 DE3221827A1 (de) 1982-06-09 1982-06-09 Biostimulierendes mittel
DE32218273 1982-06-09

Publications (2)

Publication Number Publication Date
AU1543283A AU1543283A (en) 1983-12-15
AU562517B2 true AU562517B2 (en) 1987-06-11

Family

ID=6165747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15432/83A Ceased AU562517B2 (en) 1982-06-09 1983-06-07 Biostimulating agent containing creatine

Country Status (7)

Country Link
EP (1) EP0098975B1 (enrdf_load_stackoverflow)
JP (1) JPS5962528A (enrdf_load_stackoverflow)
AT (1) ATE15604T1 (enrdf_load_stackoverflow)
AU (1) AU562517B2 (enrdf_load_stackoverflow)
DE (1) DE3221827A1 (enrdf_load_stackoverflow)
GR (1) GR77543B (enrdf_load_stackoverflow)
NO (1) NO832057L (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183084T1 (de) * 1991-05-14 1999-08-15 Ernir Snorrason Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren
RU2124360C1 (ru) * 1992-11-06 1999-01-10 Борис Геннадиевич Хорхорин Способ повышения иммунитета
CH688760A5 (de) * 1995-04-28 1998-03-13 Synergen Ag Topisches Praeparat zur Foerderung des Muskelaufbaus.
DE19537494C2 (de) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Kreatin zum Schutz von neuralem Gewebe
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink
US8603546B2 (en) 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
AU2504200A (en) * 1999-01-11 2000-08-01 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
AU5359801A (en) * 2000-04-19 2001-11-07 Humanetics Corp A combination of pinitol and creatine to enhance uptake and retention of creatine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2254777A (en) * 1936-08-26 1941-09-02 Walther H Duisberg Process of producing artificial staple fibers resembling wool
GB1012121A (en) * 1961-03-13 1965-12-08 Yamanouchi Pharma Co Ltd A method of preparing a pharmacologically active protein material from royal bee jelly
FR1326611A (fr) * 1962-04-05 1963-05-10 Procédé d'activation de la gelée royale d'abeilles, produits pour la réalisationdu procédé et produits conformes à ceux obtenus par le présent procédé ou procédé similaire

Also Published As

Publication number Publication date
DE3221827A1 (de) 1983-12-15
GR77543B (enrdf_load_stackoverflow) 1984-09-24
NO832057L (no) 1983-12-12
AU1543283A (en) 1983-12-15
EP0098975A1 (de) 1984-01-25
ATE15604T1 (de) 1985-10-15
EP0098975B1 (de) 1985-09-18
JPS5962528A (ja) 1984-04-10

Similar Documents

Publication Publication Date Title
PH21250A (en) Sucralfate supsension
CA2054358A1 (en) High acid nutritional formulations
AU566955B2 (en) Antidiarrheal compositions containing bismuth subsalicylate
ZA845833B (en) Anti-viral compositions
AU553789B2 (en) Glycyrrhetinic acid derivatives in cream compositions
EP0343444A3 (en) Cosmetic composition containing retinyl palmitate
AU562517B2 (en) Biostimulating agent containing creatine
EP0297563A3 (en) Anticariogenic and anticalculus compositions containing zeolitic zinc cations
AU5425886A (en) Anticalculus oral composition containing phosphonoformic acid
DE3269331D1 (en) Arene-carboxylic acid derivatives used as agents having an anti-seborrhea effect contained in cosmetic compositions
GR3005282T3 (enrdf_load_stackoverflow)
AU569176B2 (en) Preparation of 2,4-dichloro-5-fluoro-benzoic acid
AU550658B2 (en) Dialkyl sulphosuccinates detergents with added magnesium ions
JPS5648857A (en) Low-protein feed
JPS57171908A (en) Agent for preventing falling-out of hair, promoting growth and occurrence of hair
EP0199257A3 (en) L-aminodicarboxylic acid esters and an edible composition containing same as sweeteners
JPS56135406A (en) Bait composition containing amidinohydrazone-oleic acid
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
AU557798B2 (en) Radiographic imaging composition
AU563760B2 (en) Etofenamate formulations
SU718502A1 (ru) Электролит дл нанесени покрытий сплавом цинк-никель
AU553454B2 (en) Preparation of 3,3:-diaminodiphenyl sulfones
JPS57177656A (en) Honey containing chlorella
AU2114283A (en) Malonic acid derivatives as pesticides